Trial Profile
Comparison of the efficacy of levonorgestrel-releasing intrauterine system and depot medroxyprogesterone as long-term maintenance therapy in patients with moderate or severe endometriosis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Feb 2011
Price :
$35
*
At a glance
- Drugs Levonorgestrel (Primary) ; Medroxyprogesterone
- Indications Endometriosis
- Focus Pharmacodynamics; Therapeutic Use
- 14 Feb 2011 New trial record